MOTS-C in Mui Ne: Cellular Energy Stress and the Science of Exercise in Hot Environments
Featured Answer: What Does MOTS-c Have to Do with Exercise in Hot Environments?
MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded by a short open reading frame within the mitochondrial 12S ribosomal RNA gene. Research suggests that it participates in cellular stress signaling and metabolic regulation, including pathways associated with AMP-activated protein kinase (AMPK).
Exercise increases the energy demand placed on skeletal muscle and can change the expression or circulating concentration of some mitochondrial-derived peptides. Separate research in mice suggests that experimental MOTS-c treatment can influence metabolic function and exercise performance. These findings provide a scientific rationale for studying the relationship between MOTS-c and exercise adaptation.
However, there is no established evidence that taking MOTS-c improves human exercise performance, increases heat tolerance, prevents heat illness, or makes exercise safer in Mui Ne’s hot conditions. A change in the body’s own MOTS-c after exercise is not equivalent to evidence that administering the peptide produces the same response.
Heat exposure also creates its own physiological demands. Sweating, increased skin blood flow, cardiovascular strain, and fluid loss are well-established responses to exercise in hot environments. The scientifically responsible approach is to investigate these processes separately rather than assume that an experimental metabolic peptide can offset heat-related risks.
Key Takeaways
- MOTS-c is a mitochondrial-derived peptide. It is encoded within mitochondrial DNA and has been studied as a potential regulator of metabolic homeostasis and cellular stress responses.
- AMPK is an important mechanistic link. Experimental research suggests that MOTS-c can influence the folate–AICAR–AMPK pathway, which is involved in cellular energy sensing.
- Exercise and MOTS-c are related research topics, but they are not interchangeable interventions. Exercise can alter endogenous mitochondrial-derived peptide responses, while experimental peptide administration has mainly been investigated in preclinical models.
- Heat stress is a distinct physiological challenge. Higher skin blood flow and sweat production support heat loss but can increase fluid losses and cardiovascular strain.
- More sweating does not prove greater metabolic benefit. Sweat production is primarily a thermoregulatory response, not a direct measure of mitochondrial efficiency, fat oxidation, or MOTS-c activity.
- Animal findings cannot establish human performance benefits. Improvements observed in mice do not prove that exogenous MOTS-c improves exercise capacity or heat tolerance in people.
- Human evidence remains limited. Research measuring endogenous MOTS-c in people does not establish the safety, effective dose, or clinical benefits of administering a MOTS-c product.
- Hydration and heat management remain essential. MOTS-c should not be considered a substitute for established measures to reduce heat-related physiological strain.
1. Introduction: Cellular Energy Meets Environmental Stress
Exercise challenges the body’s energy systems. Contracting muscles require more ATP, the heart must support increased circulation, and the body must regulate temperature as metabolic heat production rises. When exercise takes place in a hot environment, the challenge becomes more complex because the body must support muscular activity while transferring heat to the surroundings.
Mui Ne provides a useful context for discussing this interaction. Warm weather, outdoor activity, and sweating can bring heat regulation and fluid balance into sharper focus. Yet these familiar physiological responses do not, by themselves, reveal how mitochondrial signaling pathways are behaving or whether an experimental peptide would change the body’s response.
MOTS-c has attracted scientific interest because it connects mitochondrial biology with cellular energy regulation. Early experiments reported effects on metabolic homeostasis, while subsequent studies have explored its relationship with exercise, aging, and stress responses.
The key question is not simply whether MOTS-c is associated with exercise. It is whether the available evidence supports a specific role for MOTS-c in human exercise adaptation, particularly when environmental heat adds physiological strain.
To answer that question, it is necessary to distinguish four areas of evidence:
- the molecular biology of MOTS-c;
- experimental findings in cells and animals;
- studies measuring endogenous MOTS-c in humans; and
- established exercise physiology in hot environments.
These evidence categories can inform one another, but they do not carry the same implications for clinical use.
2. What Is MOTS-c?
MOTS-c stands for mitochondrial open reading frame of the 12S rRNA type-c. It is a short peptide consisting of 16 amino acids, encoded by a small open reading frame within the mitochondrial MT-RNR1 region, which encodes mitochondrial 12S ribosomal RNA.
Unlike the familiar model in which mitochondrial DNA is discussed primarily in relation to mitochondrial protein synthesis, mitochondrial-derived peptides are studied as signaling molecules. They may help communicate metabolic conditions between cellular compartments and influence responses to physiological stress.
Mitochondria are best known for their role in ATP production through oxidative phosphorylation. However, they also participate in redox regulation, cellular signaling, metabolic sensing, and responses to changes in nutrient availability and energy demand.
MOTS-c is one candidate within this broader mitochondrial signaling system. Research has examined whether it helps coordinate cellular responses when energy metabolism is challenged.
2.1 MOTS-c is not the same as mitochondrial energy production
MOTS-c should not be confused with ATP, a mitochondrial enzyme, or a direct measure of mitochondrial performance. It is a signaling peptide studied for its potential effects on metabolic pathways.
Detecting MOTS-c, changing its concentration, or observing a response in a laboratory experiment does not automatically demonstrate that mitochondria produce more ATP, that muscle becomes more efficient, or that whole-body exercise capacity improves.
2.2 Endogenous and administered MOTS-c are different research questions
Endogenous MOTS-c is produced within the biological system. Researchers can investigate its concentration in tissues or circulation and observe how it changes in relation to exercise or metabolic conditions.
Administered MOTS-c refers to an externally supplied peptide used experimentally. This introduces additional questions about formulation, absorption, distribution, degradation, target engagement, dose-response relationships, and safety.
A human study showing that endogenous MOTS-c changes after exercise does not establish that an administered MOTS-c product reproduces that response. This distinction is central to interpreting the current literature.
3. Cellular Energy Stress and the AMPK Connection
AMP-activated protein kinase, or AMPK, is a cellular energy sensor. It responds to changes in cellular energy status and helps coordinate processes involved in energy production and use.
When energy demand increases or cellular energy balance is disrupted, AMPK signaling can influence glucose uptake, lipid metabolism, mitochondrial-related processes, and other pathways. AMPK also participates in exercise-related signaling, although the adaptations produced by exercise involve many overlapping pathways rather than one master switch.
The original MOTS-c discovery study, published in Cell Metabolism in 2015, reported that MOTS-c influenced skeletal-muscle metabolism and activated AMPK-associated signaling in experimental systems. The study linked these effects to disruption of the folate cycle and de novo purine biosynthesis, involving the metabolite AICAR.
This mechanism is biologically interesting because the folate cycle and purine biosynthesis are connected to cellular metabolism. Changes in these processes can influence signals associated with energy stress and AMPK activity.
3.1 The folate–AICAR–AMPK pathway
In the experimental model proposed by the discovery study, MOTS-c altered folate-cycle and purine-biosynthesis activity. These changes were associated with increased AICAR-related signaling and AMPK activation.
Researchers subsequently explored the implications for insulin sensitivity, glucose regulation, and metabolic homeostasis. Studies in mice reported that experimental MOTS-c treatment could counter some effects of age-associated or diet-associated metabolic dysfunction.
These findings provide mechanistic hypotheses for further investigation. They do not establish that MOTS-c administration has the same effects in humans, particularly under heat stress or during strenuous exercise.
3.2 Why AMPK does not explain the whole exercise response
Exercise activates a network of pathways involving energy sensing, calcium signaling, redox responses, substrate availability, mechanical stress, and gene regulation. AMPK is important, but it is not the only regulator of adaptation.
Even if MOTS-c affects AMPK-associated signaling in an experimental model, it does not follow that adding MOTS-c to exercise will reproduce all the adaptations caused by exercise itself. Nor does it establish that a peptide can substitute for training or compensate for environmental stress.
A molecular pathway can explain how a biological effect might occur, but a mechanism is not proof of a useful clinical outcome. For MOTS-c, the path from AMPK-related activity in experimental systems to improved human exercise performance in hot environments remains unestablished.
4. What Did the Original MOTS-c Discovery Study Show?
The 2015 study by Lee and colleagues identified MOTS-c as a mitochondrial-derived peptide and investigated its metabolic effects in cellular and animal models.
The researchers reported that MOTS-c acted on skeletal-muscle-related metabolic pathways and influenced AMPK signaling. In mice, experimental treatment was associated with protection against some forms of diet-induced obesity and insulin resistance, as well as changes in metabolic regulation.
These results helped establish MOTS-c as a research target linking mitochondrial signaling with whole-body metabolic homeostasis.
However, the experimental design matters. Findings from cultured cells and mice cannot directly establish the safety, effective dose, pharmacokinetics, or clinical efficacy of an administered MOTS-c product in humans.
The discovery study was not a clinical trial demonstrating that MOTS-c improves human endurance, protects against overheating, or makes exercise more effective in hot weather.
5. MOTS-c and Exercise: What Does the Literature Suggest?
Exercise is a physiological stressor that increases the demand for energy in working muscles. The resulting metabolic and mitochondrial responses are part of the body’s adaptation to repeated physical activity.
A 2021 review by Merry and colleagues examined the relationship between mitochondrial-derived peptides and exercise. The review discussed evidence that acute high-intensity exercise in humans can increase concentrations of some mitochondrial-derived peptides, including MOTS-c, in skeletal muscle or circulation.
The authors also emphasized that responses to exercise may depend on the peptide measured, tissue, exercise mode, intensity, duration, and characteristics of the participants. Evidence for persistent changes after exercise training was less consistent.
The review also summarized animal research in which MOTS-c treatment improved exercise capacity or produced metabolic adaptations resembling some effects associated with physical activity. However, experimental studies suggested that the pathways engaged by MOTS-c and exercise can be distinct as well as overlapping.
5.1 Acute exercise is not the same as long-term training adaptation
An acute response is a change measured around a single exercise session. It may reflect a temporary response to energy demand, stress signaling, or other immediate physiological changes.
A training adaptation is a longer-term change that develops after repeated exercise exposure. Examples include changes in aerobic capacity, muscle oxidative function, and the regulation of metabolic pathways.
A peptide concentration that rises after one exercise session cannot, on its own, demonstrate that the peptide causes training adaptation. To establish causality, research needs to show more than a correlation between exercise and peptide concentration.
5.2 Endogenous MOTS-c does not establish the efficacy of peptide products
Studies measuring the body’s own MOTS-c are relevant to understanding human biology. They can help researchers determine whether the peptide responds to exercise or varies with metabolic conditions.
However, these studies do not automatically answer whether an externally administered MOTS-c product is absorbed, reaches relevant tissues, activates the same pathways, or improves clinical outcomes.
Those questions require direct human studies of the administered product, with adequate characterization of the formulation, exposure, safety, and relevant endpoints.
6. What Happens to the Body During Exercise in Hot Environments?
Exercise in hot conditions creates additional demands beyond the energy requirements of muscle contraction. The body must dissipate heat while maintaining blood flow to working muscles and vital organs.
As heat production rises, skin blood flow and sweat production increase. Evaporation of sweat supports heat loss, but sweating also removes water and electrolytes from the body.
Prolonged exercise in the heat can increase cardiovascular strain and impair endurance performance, particularly when body temperature rises substantially or fluid losses are not adequately managed.
6.1 Sweating is part of thermoregulation
Sweat production is a mechanism for cooling the body. It does not directly measure mitochondrial efficiency, AMPK activation, MOTS-c concentration, or fat oxidation.
People can sweat different amounts during similar activities because sweat rate depends on environmental conditions, exercise intensity, body size, acclimatization, clothing, and individual physiology.
Consequently, a higher sweat rate in Mui Ne does not demonstrate that cellular energy pathways are working better or that an experimental peptide is improving exercise adaptation.
6.2 Heat stress and dehydration can increase physiological strain
When fluid losses exceed replacement, body water decreases. This can reduce plasma volume and challenge circulation and temperature regulation. Dehydration can therefore make exercise in the heat more difficult and can contribute to heat-related illness.
Heat exposure and exercise should be treated as real physiological stressors, not as opportunities to force a greater metabolic response through overheating or deliberate fluid restriction.
6.3 Heat acclimatization is an established area of research
Sports-medicine consensus recommendations describe heat acclimatization as an important strategy for reducing physiological strain during exercise in hot environments. Repeated, appropriately managed exposure over time can produce adaptations in thermoregulation and exercise responses.
This is a separate evidence base from MOTS-c research. There is currently no established evidence that administering MOTS-c reproduces heat acclimatization or makes deliberate exposure to high temperatures safe.
7. Is There Evidence That MOTS-c Improves Heat Tolerance?
The key distinction is between research on cellular energy stress, research on exercise, and research on heat tolerance. These are related topics, but each requires its own evidence.
Experimental findings linking MOTS-c with metabolic regulation may justify studying whether it participates in responses to physiological stress. Research on endogenous MOTS-c after exercise may help identify associations with energy demand.
Neither finding establishes that administering MOTS-c improves heat tolerance in humans.
To support such a claim, researchers would need appropriate human studies with clearly defined heat-exposure conditions and relevant endpoints. Depending on the research question, those endpoints might include core temperature responses, cardiovascular strain, thermoregulatory responses, exercise capacity, symptoms, and safety outcomes.
It would also be necessary to distinguish the effects of the peptide from those of exercise intensity, hydration, environmental temperature, acclimatization, and other variables.
Without this evidence, claims that MOTS-c protects against heat stress, enhances hot-weather endurance, or prevents heat illness remain unproven.
8. Why Mui Ne Is a Useful Context—but Not a Special MOTS-c Model
Mui Ne’s warm coastal environment is relevant to discussions of outdoor exercise because temperature, humidity, sunlight, and physical activity can influence heat load and sweat losses.
However, the location itself does not change the evidentiary requirements for MOTS-c. The biological effects of an experimental peptide cannot be inferred from the fact that an individual is exercising in a hot climate.
Three questions should remain separate:
- What does heat do to exercise physiology? Established research shows that heat increases thermoregulatory demands and can impair prolonged exercise capacity.
- What does exercise do to endogenous MOTS-c? Early human research suggests that acute exercise may change MOTS-c concentrations, but responses and longer-term patterns require further study.
- Does administered MOTS-c improve exercise in the heat? This remains unestablished in humans.
Keeping these questions separate prevents a plausible scientific narrative from becoming an unsupported product claim.
9. Hydration, Recovery, and Safety During Exercise in the Heat
Hydration and heat management have a stronger evidence base than claims about MOTS-c as a heat-performance aid.
Consensus guidance for exercise in hot environments emphasizes starting activity in an adequately hydrated state, minimizing excessive fluid loss, allowing opportunities for cooling, and considering acclimatization. Appropriate strategies vary with activity duration, environmental conditions, individual sweat losses, and health status.
There is no single fluid target that is appropriate for every person and every exercise setting. Both inadequate fluid replacement and excessive fluid intake can create problems in certain circumstances.
People with underlying medical conditions or medications that affect fluid balance may need individualized advice from a qualified healthcare professional.
During or after exercise in hot conditions, symptoms such as confusion, collapse, severe weakness, or signs of serious heat illness require urgent attention. Such symptoms should not be interpreted as evidence of beneficial cellular stress or a desired response to an experimental peptide.
MOTS-c should not be used as a substitute for established heat-safety measures. Nor should an experimental compound be assumed to reduce the consequences of dehydration, hyperthermia, or excessive exercise intensity.
A peptide may participate in biological responses to stress without being proven to prevent harm when the stressor becomes excessive. Cellular signaling, physiological adaptation, and clinical protection are different levels of evidence. MOTS-c research has not established that administering the peptide protects people from heat-related illness.
10. What Do We Know About MOTS-c Safety and Human Evidence?
The main limitation is the gap between promising preclinical biology and a well-characterized human therapeutic evidence base.
Studies of endogenous MOTS-c in humans can provide information about biological associations, but they do not establish the safety of an administered product. Likewise, findings in mice cannot be used to determine a safe or effective human dose.
The U.S. Food and Drug Administration’s published assessment of MOTS-c-related bulk drug substances identifies important evidence gaps. The agency notes that it has not identified human exposure data for drug products containing MOTS-c administered by any route, and raises concerns about peptide characterization, peptide-related impurities, potential aggregation, and immunogenicity.
This regulatory assessment is specific to the FDA’s evaluation of nominated substances for compounding in the United States. It should not be represented as a statement of Vietnamese regulatory law. It does, however, illustrate why the absence of robust human safety and exposure data matters when assessing claims about experimental peptide products.
Several questions remain important for future research:
- How is externally administered MOTS-c absorbed, distributed, metabolized, and eliminated in humans?
- What concentrations, if any, are associated with target engagement in relevant tissues?
- Are any observed effects reproducible across human populations?
- Does administration produce measurable benefits beyond those associated with exercise itself?
- What adverse effects, immunogenicity risks, or product-quality problems might occur?
- Can a benefit be demonstrated for a defined clinical or performance endpoint rather than inferred from a molecular mechanism?
Until these questions are answered by appropriate studies, efficacy and safety claims for externally administered MOTS-c should be treated cautiously.
11. Clinical Evidence Snapshot: MOTS-c, Exercise, and Heat Stress
| Evidence source | Research focus | Main finding | What it does not establish |
|---|---|---|---|
| Lee et al., 2015, Cell Metabolism | MOTS-c discovery and metabolic mechanisms. | Reported a 16-amino-acid mitochondrial-derived peptide associated with folate–AICAR–AMPK signaling and metabolic effects in experimental models. | Human efficacy, safe dosing, heat tolerance, or improved human exercise performance. |
| Merry et al., 2021, BBA – General Subjects | Review of mitochondrial-derived peptides and exercise. | Summarized evidence that acute high-intensity exercise can alter MOTS-c and other mitochondrial-derived peptide responses in humans, with mixed evidence for chronic training effects. | That administering MOTS-c produces the same response or improves performance in people. |
| Wan et al., 2023, Journal of Translational Medicine | Review of MOTS-c mechanisms in stress, metabolism, and aging. | Discussed the proposed role of MOTS-c in metabolic regulation and stress-response signaling. | Clinical proof that MOTS-c prevents aging-related disease or heat-related illness. |
| Racinais et al., 2015, consensus recommendations | Exercise and sports performance in hot environments. | Described thermoregulatory strain, the effects of dehydration, and the importance of heat acclimatization and hydration management. | Any MOTS-c-specific effect or benefit from administering an experimental peptide. |
| Zhou et al., 2024, systematic review and meta-analysis | Associations between mitochondrial-derived peptides and metabolic states. | Reviewed observational associations between mitochondrial-derived peptides and metabolic conditions. | Causation, therapeutic efficacy, or the safety of exogenous MOTS-c. |
| U.S. FDA MOTS-c assessment | Potential safety concerns for nominated MOTS-c-related bulk substances in compounding. | Identified major gaps in human exposure data and concerns relating to characterization, impurities, aggregation, and potential immunogenicity. | A finding that every product marketed under the MOTS-c name has the same composition or risk profile, or a statement of Vietnamese law. |
12. How to Evaluate Claims About MOTS-c and Exercise Performance
Claims about an experimental peptide are more informative when they are linked to a clearly defined outcome and a specific type of evidence.
For example, a statement that MOTS-c is associated with AMPK signaling is a mechanistic claim. A statement that endogenous MOTS-c changes after exercise is a physiological observation. A statement that administered MOTS-c improves endurance in humans is a clinical efficacy claim.
These statements require different kinds of evidence.
When evaluating a product description or research summary, consider the following distinctions:
- Mechanistic plausibility: Does a study identify a plausible pathway, and in which experimental system?
- Preclinical efficacy: Was an effect demonstrated in cells or animals, and what were the model’s limitations?
- Human association: Was MOTS-c measured in people, and was the study observational or interventional?
- Human intervention evidence: Was an administered MOTS-c product actually studied in humans?
- Relevant outcomes: Did the research measure exercise performance, heat tolerance, safety, or only a molecular marker?
- Product identity and quality: Is the tested material adequately characterized, and can the findings be linked to the product being discussed?
This framework helps prevent a common error: treating an interesting biological mechanism as proof that a commercial product will produce a specific outcome.
13. Frequently Asked Questions
MOTS-c is a short, 16-amino-acid peptide encoded by a region of mitochondrial DNA. Researchers study it as a signaling molecule potentially involved in metabolic regulation and cellular stress responses.
Experimental research has linked MOTS-c to the folate–AICAR–AMPK pathway. AMPK is a cellular energy sensor involved in coordinating energy metabolism. This mechanistic connection does not by itself establish a clinical benefit in humans.
Research reviewed by Merry and colleagues suggests that acute high-intensity exercise can alter endogenous MOTS-c levels in skeletal muscle or circulation. Responses may depend on the exercise protocol, tissue, and participant characteristics, and evidence for chronic training-related changes is less consistent.
No. A change in endogenous MOTS-c after exercise is not proof that administering the peptide improves performance. Human intervention evidence is required to establish whether an administered product has a reproducible benefit and an acceptable safety profile.
That benefit has not been established in humans. Heat tolerance depends on several physiological and environmental factors, and current evidence does not show that administering MOTS-c prevents heat-related illness or replaces established heat-management practices.
No. Sweating is primarily a thermoregulatory response. Sweat rate is not a validated marker of MOTS-c activity, mitochondrial efficiency, or metabolic benefit.
No. Animal studies can identify biological mechanisms and generate hypotheses, but differences in physiology, exposure, metabolism, and experimental conditions mean that efficacy and safety must be evaluated in humans before clinical conclusions can be drawn.
The available evidence does not establish MOTS-c as an approved treatment for metabolic disease, aging, or age-related conditions. Experimental findings should not be presented as proof of disease prevention or treatment.
The FDA’s assessment of nominated MOTS-c-related bulk substances describes gaps in human exposure data and concerns about peptide characterization, impurities, aggregation, and potential immunogenicity. These concerns illustrate why product quality and human safety evidence matter. The assessment is specific to the U.S. regulatory context.
There is no evidence supporting that substitution. Hydration management, appropriate heat exposure, cooling opportunities, and recognition of heat-illness symptoms remain important aspects of exercise safety in hot environments.
A useful study would clearly characterize the product and exposure, include appropriate controls, monitor adverse events, and use predefined outcomes relevant to the claim—such as metabolic function, exercise performance, or heat-related physiological responses. A change in a biomarker alone would not establish a meaningful clinical benefit.
14. Related Research Products and Educational Resources
MOTS-C 20mg — Research Product Information
This listing relates to MOTS-c, the mitochondrial-derived peptide discussed in this article. The product title does not establish verified identity, purity, sterility, regulatory approval, clinical effectiveness, or suitability for human use. Findings from published studies apply to the specific materials, experimental systems, and conditions studied.
SLU-PP-332 5mg — Related Exercise-Mimetic Research Topic
SLU-PP-332 is an experimental compound studied in relation to exercise-associated metabolic pathways. It is not MOTS-c, and evidence about one compound cannot be transferred to the other. The phrase “exercise mimetic” describes a research concept and should not be interpreted as proof of equivalent benefits or safety in humans.
- Knowledge Hub — explore educational content on peptide biology and research evidence.
- Peptide FAQ — review general questions about research peptides and the limits of product claims.
- Peptide Products and Research Information — distinguish product descriptions from independently established scientific findings.
Related Educational Resource: Longevity Peptide Plan
The Longevity Peptide Plan is a related educational resource for readers exploring longevity-focused peptide research. It should not be interpreted as a personalized treatment recommendation or as evidence that an investigational compound extends human lifespan or improves heat tolerance.
15. Scientific References
- Lee C, Zeng J, Drew BG, et al. The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance. Cell Metabolism. 2015;21(3):443–454. DOI: 10.1016/j.cmet.2015.02.009. https://doi.org/10.1016/j.cmet.2015.02.009.
- Merry TL, Chan A, Woodhead JST, Reynolds JC, Kumagai H, Kim SJ, Lee C, Ghosh P, Emanuele E, Sweeney G, Philp A. Mitochondrial-derived peptides and exercise. Biochimica et Biophysica Acta (BBA) – General Subjects. 2021;1865(12):130011. DOI: 10.1016/j.bbagen.2021.130011. PubMed.
- Wan W, Zhang L, Lin Y, et al. Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging. Journal of Translational Medicine. 2023;21:36. DOI: 10.1186/s12967-023-03885-2. https://doi.org/10.1186/s12967-023-03885-2.
- Kim SJ, Mehta HH, Wan J, et al. Mitochondrial-derived peptides in energy metabolism. Journal of Physiology. 2018/2020 review record. PubMed Central review.
- Zhou Q, Yin S, Lei X, et al. The correlation between the mitochondrial derived peptide (MDP) and metabolic states: a systematic review and meta-analysis. Diabetology & Metabolic Syndrome. 2024;16:200. https://doi.org/10.1186/s13098-024-01405-w.
- Racinais S, Alonso JM, Coutts AJ, et al. Consensus recommendations on training and competing in the heat. Sports Medicine. 2015;45(7):925–938. DOI: 10.1007/s40279-015-0343-6. Full text.
- International Olympic Committee. IOC consensus statement on recommendations and regulations for sport events in the heat. British Journal of Sports Medicine. 2023. Full text.
- U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. FDA assessment includes MOTS-c-related substances and identifies gaps in human exposure data and concerns about characterization, impurities, aggregation, and potential immunogenicity. FDA resource.
Conclusion: Separate Cellular Signaling from Proven Human Performance
MOTS-c is an important research candidate because it connects mitochondrial-derived signaling with cellular energy regulation. Experimental findings involving the folate–AICAR–AMPK pathway and metabolic effects in animals provide a rationale for further investigation. Research on exercise also suggests that endogenous mitochondrial-derived peptides can respond to physiological demand.
But the evidence has boundaries. A peptide’s association with exercise does not establish that administering it improves human performance. A metabolic mechanism does not establish heat protection, and results from animal models do not demonstrate clinical efficacy in people.
In Mui Ne and other hot environments, exercise places additional demands on thermoregulation, cardiovascular function, and fluid balance. These effects are supported by established exercise-physiology research. There is currently no adequate basis for treating MOTS-c as a proven method for improving heat tolerance or replacing established heat-safety measures.
The key principle: MOTS-c is a promising subject for mitochondrial and metabolic research, not an established human exercise or heat-protection treatment. The strongest interpretation of the literature separates mechanistic plausibility, preclinical results, human biomarker observations, and demonstrated clinical outcomes.